Clinical Radiology
Volume 65, Issue 4 , Pages 278-287 , April 2010

Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism

  • C.N. Patel

      Affiliations

    • Department of Radiology and Nuclear Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    • Corresponding Author InformationGuarantor and correspondent. C.N. Patel, Department of Nuclear Medicine, Bexley Wing, St James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK. Tel.: +44 113 2068212; fax: +44 113 2068228.
    • ,
  • H.M. Salahudeen

      Affiliations

    • Department of Radiology and Nuclear Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    • ,
  • M. Lansdown

      Affiliations

    • Department of Endocrine Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    • ,
  • A.F. Scarsbrook

      Affiliations

    • Department of Radiology and Nuclear Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Received 21 September 2009 ,Revised 30 November 2009 ,Accepted 3 December 2009.

References 

  1. Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995–2003. Otolaryngol Head Neck Surg. 2005;132:359–372
  2. Udelsman R. Six hundred and fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:655–670
  3. Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am J Roentgenol. 2007;188:1706–1715
  4. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95:14–21
  5. Patel CN, Chowdhury FU, Scarsbrook AF. Clinical utility of hybrid SPECT-CT in endocrine neoplasia. AJR Am J Roentgenol. 2008;190:815–824
  6. Profanter C, Wetscher GJ, Gabriel M, et al. CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent and persistent hyperparathyroidism. Surgery. 2004;135:157–162
  7. Krausz Y, Bettman L, Guralnik L, et al. Technetium-99 m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg. 2006;30:76–83
  8. Gayed IW, Kim EE, Broussard WF, et al. The value of 99m Tc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46:248–252
  9. Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med. 2008;49:2012–2017
  10. Akram K, Parker JA, Donohoe K, et al. Role of single photon emission computed tomography/computed tomography in localization of ectopic parathyroid adenoma: a pictorial case series and review of the current literature. Clin Nucl Med. 2009;34:500–502
  11. Norman J, Shheda H, Farrel C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results. Am Surg. 1998;64:391–396
  12. Mariani G, Gulec SA, Rubello D, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003;44:1443–1458
  13. Henry JF, Iacobone M, Mirallie E, et al. Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism. Surgery. 2001;130:999–1004
  14. Kebapci M, Entok E, Kebapci N, et al. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J Endocrinol Invest. 2004;27:24–30
  15. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m) technetium sestamibi scintigraphy. Clin Endocrinol. 2002;57:241–249
  16. Tublin ME, Pryma DA, Yim JH, et al. Localization of parathyroid adenomas by sonography and technetium 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?. J Ultrasound Med. 2009;28:183–190
  17. Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med. 2005;30:1–3
  18. Lavely WC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084–1089
  19. Sharma J, Mazzaglia P, Milas M, et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?. Surgery. 2006;140:856–863
  20. Civelek AC, Ozalp E, Donovan P, et al. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131:149–157
  21. Hindié E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Urena P. Parathyroid task group of the EANM. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–1216
  22. Harris L, Yoo J, Driedger A, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intra-operative anatomical location of parathyroid adenomas. Head Neck. 2008;30:509–517
  23. Mihai R, Gleeson F, Buley ID, et al. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high resolution ultrasound scanning with histological analysis in 150 patients. World J Surg. 2006;30:697–704
  24. Gupta Y, Ahmed R, Happerfield L, et al. P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism. Br J Surg. 2007;94:1491–1495
  25. Jorna FH, Hollema H, Hendrikse HN, et al. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and 99m Tc-sestamibi imaging results. Exp Clin Endocrinol Diabetes. 2009;doi: 10.1055/s-0028-1105925
  26. Lumachi F, Zucchetta P, Marzola MC, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol. 2000;143:755–760
  27. Siperstein A, Berber E, Mackey R, et al. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136:872–880
  28. Purcell GP, Dirbas FM, Jeffrey RB, et al. Parathyroid localization with high-resolution ultrasound and technetium 99mTc sestamibi. Arch Surg. 1999;134:824–830
  29. De Feo ML, Colagrande S, Biagini C, et al. Parathyroid glands: combination of (99m) Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology. 2000;214:393–402
  30. Administration of Radioactive Substances Advisory Committee (ARSAC) . Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Oxon: ARSAC; 2006;
  31. Sawyer LJ, Starritt HC, Hiscock SC, et al. Effective doses to patients from CT acquisition on the GE Infinia Hawkeye: a comparison of calculation methods. Nucl Med Commun. 2008;29:144–149

PII: S0009-9260(10)00024-3

doi: 10.1016/j.crad.2009.12.005

Clinical Radiology
Volume 65, Issue 4 , Pages 278-287 , April 2010

Article Tools

* Image Usage & Resolution